Fig. 3
From: Clinical and pathological staging of the cancer at the nanoscale
Conformity of the percent unlabeled fraction of tumor by tritiated thymidine and the malignant fraction in each tumor
Fig. 3 | Cancer Nanotechnology
From: Clinical and pathological staging of the cancer at the nanoscale
Conformity of the percent unlabeled fraction of tumor by tritiated thymidine and the malignant fraction in each tumor